**Infliximab**, a chimeric monoclonal antibody, sold under the brand name **Remicade** among others, is a medication used to treat a number of [autoimmune diseases](https://en.wikipedia.org/wiki/Autoimmune_diseases "Autoimmune diseases"). This includes [[Crohn's Disease|Crohn's disease]], [[Ulcerative Colitis|ulcerative colitis]], [rheumatoid arthritis](https://en.wikipedia.org/wiki/Rheumatoid_arthritis "Rheumatoid arthritis"), [ankylosing spondylitis](https://en.wikipedia.org/wiki/Ankylosing_spondylitis "Ankylosing spondylitis"), [psoriasis](https://en.wikipedia.org/wiki/Psoriasis "Psoriasis"), [psoriatic arthritis](https://en.wikipedia.org/wiki/Psoriatic_arthritis "Psoriatic arthritis"), and [Behçet's disease](https://en.wikipedia.org/wiki/Beh%C3%A7et%27s_disease "Behçet's disease"). It is given by [slow injection into a vein](https://en.wikipedia.org/wiki/Intravenous_therapy "Intravenous therapy"), typically at six- to eight-week intervals. Developed by [[Janssen Pharmaceuticals]].